# Pulsed Field Ablation Outcomes With Efficacy and Randomization in Atrial Fibrillation (POWER-AF)

Study · id `cardio:ct-nct07601763` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07601763](<https://clinicaltrials.gov/study/NCT07601763>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07601763

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1574 participants.

## Technical summary

Registry record NCT07601763. Randomized; single masking; primary purpose treatment. Start 2025-04-16 (actual); primary completion 2027-11-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1574 participants (planned count; ClinicalTrials.gov record NCT07601763, source copy `cardio:ctgov-nct07601763-2026-05-28`, retrieved 2026-10-26)
- Started: 2025-04-16 (actual) (ClinicalTrials.gov record NCT07601763, source copy `cardio:ctgov-nct07601763-2026-05-28`, retrieved 2026-10-26)
- Primary completion: 2027-11-30 (anticipated) (ClinicalTrials.gov record NCT07601763, source copy `cardio:ctgov-nct07601763-2026-05-28`, retrieved 2026-10-26)
- Completion: 2028-11-30 (anticipated) (ClinicalTrials.gov record NCT07601763, source copy `cardio:ctgov-nct07601763-2026-05-28`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07601763, source copy `cardio:ctgov-nct07601763-2026-05-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07601763-2026-05-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pulsed Field Ablation Outcomes With Efficacy and Randomization in Atrial Fibrillation (POWER-AF)
- Acronym: POWER-AF
- Condition: Atrial Fibrillation (AF)
- Condition: Atrial Fibrillation Ablation
- Condition: Atrial Fibrillation Recurrent
- Condition: Pulsed Field Ablation
- Condition: Radiofrequency Catheter Ablation
- Intervention (Procedure): Pulsed field ablation
- Intervention (Procedure): Radiofrequency ablation alone
- Intervention (Device): Pulsed field ablation system
- Lead sponsor: China National Center for Cardiovascular Diseases
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: China National Center for Cardiovascular Diseases (`cardio:org-china-national-center-for-cardiovascular-diseases`)

## Provenance

Content hash: 0cede7f284cc13158c64a40d07c21188681c67987ffaecce0f96697993081c06
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
